Wael N Jarjour

Title: Wael N Jarjour: Innovator in MicroRNA Inhibitor Therapy

Introduction

Wael N Jarjour is a prominent inventor based in Columbus, OH (US). He has made significant contributions to the field of medical research, particularly in the treatment of systemic lupus erythematosus (SLE). His innovative approach has the potential to change the landscape of therapies available for this challenging autoimmune disease.

Latest Patents

Jarjour holds a patent for "MicroRNA inhibitor therapy in systemic lupus erythematosus." This patent discloses novel compositions and methods for treating SLE, along with a model for measuring the efficacy of these treatments. Specifically, the patent provides a non-human animal model for SLE, which includes a severe combined immunodeficient non-human animal that comprises exogenous cells from a human subject with SLE. The cells from the human subject are peripheral blood mononuclear cells. Additionally, the patent outlines a method for screening drug candidates that inhibit or reduce SLE using this animal model.

Career Highlights

Jarjour is associated with the Ohio State Innovation Foundation, where he continues to advance his research and development efforts. His work is characterized by a commitment to finding effective treatments for complex diseases, showcasing his dedication to improving patient outcomes.

Collaborations

Some of his notable coworkers include Giancarlo Valiente and Nicholas E Young. Their collaborative efforts contribute to the innovative research environment at the Ohio State Innovation Foundation.

Conclusion

Wael N Jarjour's contributions to the field of medical research, particularly through his patent on MicroRNA inhibitor therapy, highlight his role as an innovator in the treatment of systemic lupus erythematosus. His work exemplifies the potential of scientific research to lead to groundbreaking therapies that can significantly impact patient care.